Victoria Martín-Yuste
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Victoria Martín-Yuste has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Diego Fernández-Rodríguez
Diego Fernández-Rodríguez, Luis Alvarez-Contreras, Victoria Martín-Yuste, Salvatore Brugaletta, Montserrat Cardona, Manel Sabaté, Department of Cardiology, Hospital Clinic, 08036 Barcelona, Spain
2 shared publicationsManel Sabaté
Diego Fernández-Rodríguez, Luis Alvarez-Contreras, Victoria Martín-Yuste, Salvatore Brugaletta, Montserrat Cardona, Manel Sabaté, Department of Cardiology, Hospital Clinic, 08036 Barcelona, Spain
2 shared publicationsSalvatore Brugaletta
Diego Fernández-Rodríguez, Luis Alvarez-Contreras, Victoria Martín-Yuste, Salvatore Brugaletta, Montserrat Cardona, Manel Sabaté, Department of Cardiology, Hospital Clinic, 08036 Barcelona, Spain
2 shared publicationsAnder Regueiro
1 shared publication- Félix Pérez-Villa
Servicio de Cardiología, Hospital Clinic i Provincial, Barcelona, Spain
1 shared publication Ignacio Ferreira
Diego Fernández-Rodríguez, Luis Alvarez-Contreras, Victoria Martín-Yuste, Salvatore Brugaletta, Montserrat Cardona, Manel Sabaté, Department of Cardiology, Hospital Clinic, 08036 Barcelona, Spain
1 shared publication
Latest Publications
- Open Access
- 1 January 2016
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 18 (1) , 78-9
Benefits of chronic total coronary occlusion percutaneous intervention in patients with heart failure and reduced ejection fraction: insights from a cardiovascular magnetic resonance study
- 1 January 2016
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 18 (1) , 78-9
Open AccessBenefits of chronic total coronary occlusion percutaneous intervention in patients with heart failure and reduced ejection fraction: insights from a cardiovascular magnetic resonance study
- Open Access
- 1 January 2014
- Published by Baishideng Publishing Group Inc. in World Journal of Cardiology
- Vol. 6 (9) , 1030-7
Does manual thrombus aspiration help optimize stent implantation in ST-segment elevation myocardial infarction?
To evaluate the impact of thrombus aspiration (TA) on procedural outcomes in a real-world ST-segment elevation myocardial infarction (STEMI) registry. From May 2006 to August 2008, 542 consecutive STEMI patients referred for primary or rescue percutaneous coronary intervention were enrolled and the angiographic results and stent implantation characteristics were compared according to the performance of manual TA. A total of 456 patients were analyzable and categorized in TA group (156 patients; 34.2%) and non-TA (NTA) group (300 patients; 65.8%). Patients treated with TA had less prevalence of multivessel disease (39.7% vs 54.7%, P = 0.003) and higher prevalence of initial thrombolysis in myocardial infarction flow < 3 (P < 0.001) than NTA group. There was a higher rate of direct stenting (58.7% vs 45.5%, P = 0.009), with shorter (24.1 ± 11.8 mm vs 26.9 ± 15.7 mm, P = 0.038) and larger stents (3.17 ± 0.43 mm vs 2.93 ± 0.44 mm, P < 0.001) in the TA group as compared to NTA group. The number of implanted stents (1.3 ± 0.67 vs 1.5 ± 0.84, P = 0.009) was also lower in TA group. In an "all-comers" STEMI population, the use of TA resulted in more efficient procedure leading to the implantation of less number of stents per lesion of shorter lengths and larger sizes.
- 1 January 2014
- Published by Baishideng Publishing Group Inc. in World Journal of Cardiology
- Vol. 6 (9) , 1030-7
Open AccessDoes manual thrombus aspiration help optimize stent implantation in ST-segment elevation myocardial infarction?
To evaluate the impact of thrombus aspiration (TA) on procedural outcomes in a real-world ST-segment elevation myocardial infarction (STEMI) registry. From May 2006 to August 2008, 542 consecutive STEMI patients referred for primary or rescue percutaneous coronary intervention were enrolled and the angiographic results and stent implantation characteristics were compared according to the performance of manual TA. A total of 456 patients were analyzable and categorized in TA group (156 patients; 34.2%) and non-TA (NTA) group (300 patients; 65.8%). Patients treated with TA had less prevalence of multivessel disease (39.7% vs 54.7%, P = 0.003) and higher prevalence of initial thrombolysis in myocardial infarction flow < 3 (P < 0.001) than NTA group. There was a higher rate of direct stenting (58.7% vs 45.5%, P = 0.009), with shorter (24.1 ± 11.8 mm vs 26.9 ± 15.7 mm, P = 0.038) and larger stents (3.17 ± 0.43 mm vs 2.93 ± 0.44 mm, P < 0.001) in the TA group as compared to NTA group. The number of implanted stents (1.3 ± 0.67 vs 1.5 ± 0.84, P = 0.009) was also lower in TA group. In an "all-comers" STEMI population, the use of TA resulted in more efficient procedure leading to the implantation of less number of stents per lesion of shorter lengths and larger sizes.
- Open Access
- 1 January 2013
- Published by Baishideng Publishing Group Inc. in World Journal of Cardiology
- Vol. 5 (10) , 391-393
Medical management of connector pin thrombosis with the Amplatzer cardiac plug left atrial closure device
Transcatheter closure of the left atrial appendage with the Amplatzer™ cardiac plug device and double antiplatelet treatment for 3 mo has become an alternative treatment for patients with atrial fibrillation at high embolism risk and contraindications for chronic oral anticoagulation. The inadequate implantation of the left atrial appendage closure device and the discontinuation of double antiplatelet therapy are well-known as factors related to device thrombosis. Nevertheless, device thrombosis after adequate implantation requiring surgical treatment or restarting chronic oral anticoagulation has been reported and can reach 15% of patients. The connector pin thrombosis of the Amplatzer™ cardiac plug, despite a good adherence to antiplatelet treatment, has been recently described as a potential mechanism for device thrombosis. Our clinical case reports the management of this condition for the first time, showing that the early detection of thrombotic complications by transesophageal echocardiography permits solving this serious complication with medical treatment only.
- 1 January 2013
- Published by Baishideng Publishing Group Inc. in World Journal of Cardiology
- Vol. 5 (10) , 391-393
Open AccessMedical management of connector pin thrombosis with the Amplatzer cardiac plug left atrial closure device
Transcatheter closure of the left atrial appendage with the Amplatzer™ cardiac plug device and double antiplatelet treatment for 3 mo has become an alternative treatment for patients with atrial fibrillation at high embolism risk and contraindications for chronic oral anticoagulation. The inadequate implantation of the left atrial appendage closure device and the discontinuation of double antiplatelet therapy are well-known as factors related to device thrombosis. Nevertheless, device thrombosis after adequate implantation requiring surgical treatment or restarting chronic oral anticoagulation has been reported and can reach 15% of patients. The connector pin thrombosis of the Amplatzer™ cardiac plug, despite a good adherence to antiplatelet treatment, has been recently described as a potential mechanism for device thrombosis. Our clinical case reports the management of this condition for the first time, showing that the early detection of thrombotic complications by transesophageal echocardiography permits solving this serious complication with medical treatment only.